Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K V Kowdley

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Gastroenterology|April 18, 1998
Evaluating TIPS trials: the devil is in the details?K V Kowdley
The Nurse Practitioner|July 1, 1996
Update on therapy for hepatobiliary diseasesK V Kowdley
Gastroenterology|October 3, 1998
Interferon alfa for chronic hepatitis C: how do we define cure?K V Kowdley
Gastroenterology|February 13, 2001
Is hepatic fibrosis reversible with therapy in hepatitis C?K V Kowdley
The American Journal of Gastroenterology|May 11, 1999
TNF-alpha in chronic hepatitis C: the smoking gun?K V Kowdley
Gastroenterology|August 28, 1999
Does interferon therapy prevent hepatocellular carcinoma in patients with chronic hepatitis C?K V Kowdley
Gastroenterology|May 29, 1999
Lamivudine for chronic hepatitis B: the magic bullet or just another bright prospect?K V Kowdley
Clinics in Liver Disease|November 25, 2004
Lipids and lipid-activated vitamins in chronic cholestatic diseasesK V Kowdley
Gastroenterology|March 4, 2000
Another link in the iron chain?K V Kowdley
The American Journal of Medicine|April 27, 2000
Ursodeoxycholic acid therapy in hepatobiliary diseaseK V Kowdley
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Gastroenterology|April 18, 1998
Evaluating TIPS trials: the devil is in the details?K V Kowdley
The Nurse Practitioner|July 1, 1996
Update on therapy for hepatobiliary diseasesK V Kowdley
Gastroenterology|October 3, 1998
Interferon alfa for chronic hepatitis C: how do we define cure?K V Kowdley
Gastroenterology|February 13, 2001
Is hepatic fibrosis reversible with therapy in hepatitis C?K V Kowdley
The American Journal of Gastroenterology|May 11, 1999
TNF-alpha in chronic hepatitis C: the smoking gun?K V Kowdley
Gastroenterology|August 28, 1999
Does interferon therapy prevent hepatocellular carcinoma in patients with chronic hepatitis C?K V Kowdley
Gastroenterology|May 29, 1999
Lamivudine for chronic hepatitis B: the magic bullet or just another bright prospect?K V Kowdley
Clinics in Liver Disease|November 25, 2004
Lipids and lipid-activated vitamins in chronic cholestatic diseasesK V Kowdley
Gastroenterology|March 4, 2000
Another link in the iron chain?K V Kowdley
The American Journal of Medicine|April 27, 2000
Ursodeoxycholic acid therapy in hepatobiliary diseaseK V Kowdley
Pageof 10